AdaptHealth

Capitated Deal And AI Automation Will Transform Home Healthcare

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

15 May 25

AnalystConsensusTarget's Fair Value

US$13.13

31.8% undervalued

04 Sep

US$8.95

-18.6%

-0.2%

-18.6%

-0.2%

You can edit this narrative until May 15 8:11 PM. Then, changes will post as Updates.

Author's Valuation

US$13.1331.8% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

US$13.13

31.8% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

6.86%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.25%

Calculation

US$157.71m

Earnings '28

14.04x

PE Ratio '28

US$2.21b

Market Cap '28

US$2.21b

Market Cap '28

134.62m

No. shares '28

US$16.45

Share Price '28

US$16.45 Share Price '28

Discounted to 2025 @ 7.97% p.a.

US$13.06

Fair Value '25